If NCM were a holding of mine I may have a different opinion, but then again with the run NCM has had of late I'd probably want to lock in a few profits also. I don't think this will retrace far below $10, if it even gets there.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
